Literature DB >> 10612305

Development of a non-transformed human liver cell line with differentiated-hepatocyte and urea-synthetic functions: applicable for bioartificial liver.

J H Yoon1, H V Lee, J S Lee, J B Park, C Y Kim.   

Abstract

There is a need to develop human hepatocyte cell lines which retain both replicating capacity and highly differentiated functions to facilitate the development of an efficient bioartificial liver. The present study was undertaken to differentiate, using sodium butyrate, the actively replicating immortalized human liver cell line. The effects of butyrate on cell growth and cell cycle were analyzed, and the albumin synthesis, cytochrome P450 and ammonia-detoxifying activity of the butyrate-treated cells were measured. Butyrate treatment resulted in G2/M arrest of the cell cycle and polygonal changes in the cell morphology. Neither the control nor the butyrate-treated cells showed transformed characteristics. Butyrate treatment increased the amount of albumin secretion, cytochrome P450 activity, and the urea production rate of the cells. The present study provides non-transformed human hepatocytes, which can replicate unlimitedly and then restore differentiated hepatocyte-specific functions by butyrate, and therefore, have applications for the development of an efficient bioartificial liver.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10612305

Source DB:  PubMed          Journal:  Int J Artif Organs        ISSN: 0391-3988            Impact factor:   1.595


  9 in total

1.  Identification of HepG2 variant cell lines by short tandem repeat (STR) analysis.

Authors:  Jos F van Pelt; Ronny Decorte; Paul S H Yap; Johan Fevery
Journal:  Mol Cell Biochem       Date:  2003-01       Impact factor: 3.396

Review 2.  Which are the right cells to be used in a bioartificial liver?

Authors:  Robert A F M Chamuleau; Tanja Deurholt; Ruurdtje Hoekstra
Journal:  Metab Brain Dis       Date:  2005-12       Impact factor: 3.584

Review 3.  Potentials of regenerative medicine for liver disease.

Authors:  Shinichiro Ogawa; Shinichi Miyagawa
Journal:  Surg Today       Date:  2009-12-08       Impact factor: 2.549

4.  Liver-specific physiology of immortal, functionally differentiated hepatocytes and of deficient hepatocyte-like variants.

Authors:  Christoph Priesner; Friedemann Hesse; Dirk Windgassen; Rainer Klocke; Dieter Paul; Roland Wagner
Journal:  In Vitro Cell Dev Biol Anim       Date:  2004 Nov-Dec       Impact factor: 2.416

5.  Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells.

Authors:  Robert E Schwartz; Morayma Reyes; Lisa Koodie; Yuehua Jiang; Mark Blackstad; Troy Lund; Todd Lenvik; Sandra Johnson; Wei-Shou Hu; Catherine M Verfaillie
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

6.  Establishment and characterisation of a novel bovine SV40 large T-antigen-transduced foetal hepatocyte-derived cell line.

Authors:  Alexander Gleich; Bastian Kaiser; Julia Schumann; Herbert Fuhrmann
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-04-12       Impact factor: 2.416

7.  Spheroid formation and functional restoration of human fetal hepatocytes on poly-amino acid-coated dishes after serial proliferation.

Authors:  Taku Matsushita; Kohji Nakano; Yasufumi Nishikura; Kenta Higuchi; Akifumi Kiyota; Ryuichi Ueoka
Journal:  Cytotechnology       Date:  2003-07       Impact factor: 2.058

Review 8.  Cell sources, liver support systems and liver tissue engineering: alternatives to liver transplantation.

Authors:  Soo Young Lee; Han Joon Kim; Dongho Choi
Journal:  Int J Stem Cells       Date:  2015-05       Impact factor: 2.500

9.  Decrease in oxidative phosphorylation yield in presence of butyrate in perfused liver isolated from fed rats.

Authors:  Jean-Louis Gallis; Pierre Tissier; Henri Gin; Marie-Christine Beauvieux
Journal:  BMC Physiol       Date:  2007-08-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.